Henkel introduces instant adhesives for medical device applications

As a manufacturer of advanced adhesive solutions for the medical industry, Henkel has introduced two next-generation medical grade, cyanoacrylates-based instant adhesives that are designed to offer improved safety and performance. The new products are formulated without CMR (Carcinogenic, Mutagenic or Reproductively hazardous) ingredients and are designed to offer increased strength during and after heat cycling. Loctite 4011S and Loctite 4061S are designed to meet the specifications of Loctite 4011 and 4061 for easier validation in existing medical applications. Both new products have been tested to ISO 10993 biocompatibility standards. The adhesives aim to develop handling strength in seconds on most substrates and aim to provide high bond strength on a range of materials including plastics, rubbers, and metals. After 1000 hours of exposure to 120°C (248°F) heat, these next generation adhesives offer approximately 100% greater shear strength on steel than other instant adhesive formulations. Henkel's new, heat-resistant instant adhesives are "excellent candidates" for bonding various types of catheters, as well as tube sets, surgical robots, and other medical housings. “Henkel is committed to medical quality systems and good manufacturing practices as a pioneer for sustainable solutions,” said Philipp Loosen, vice president and head of industrials EIMEA and global key accounts medical at Henkel. “The launch of these new, next generation instant adhesives are formulated to meet the highest safety standards, addressing the need for safe and effective medical device assemblies, and demonstrating our longstanding commitment to the medical industry.” For more information about Loctite 4011S and Loctite 4061S, Henkel will be at MD&M West from 6-8th February in Anaheim, CA, at booth #2326.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。